Exploring the Optimal Way to Measure & Monitor AAV Safety Signals in the CNS
Time: 9:30 am
day: Day Two
Details:
• Assessing the accuracy of imaging technology to inform on the AAV safety profile
• Identifying novel strategies to facilitate monitoring by using biomarkers
• Investigating CNS gene therapy deliver method to minimize safety events
